Italy: pioneering pay for performance in the age of austerity
January 4, 2011Sales and Marketing Drug pricing, Italy, cancer drug prices, price cuts
2010 saw Europe beset by economic turmoil, as governments have struggled with the effects of the downturn, including considerable public …
Novartis adds R&D unit to new vaccines plant
December 31, 2010Manufacturing and Production, Research and Development Novartis, pharma manufacturing, vaccines
Swiss drugmaker Novartis is planning to spend $36 million to set up an R&D laboratory on the site of its …
US healthcare ‘extreme makeover’ predicted for 2011
December 31, 2010Sales and Marketing US, US health reforms, US healthcare, health organisations, pricewaterhousecoopers, pwC
Health organisations in the US will undergo a strategic makeover in 2011 as they react to the pressures from new …
VTE trial boost for Pfizer and BMS’ apixaban
December 31, 2010Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, Pfizer, VTE, apixaban, enoxaparin, venous thromboembolism
Pfizer and Bristol-Myers Squibb’s oral anticoagulant apixaban has shown benefits over a standard injectable treatment for venous thromboembolism in a …
UCB plans €250m plant to meet Cimzia demand
December 29, 2010Manufacturing and Production Cimzia, Switzerland, UCB, pharma manufacturing
Belgian biotechnology company UCB has started construction of a new microbial manufacturing facility in Bulle, Switzerland to help meet demand …
SHL Expands Range of Automation Solutions for Auto Injector Assembly
December 29, 2010Manufacturing and Production assembly, auto injector, autoinjector, shl group
December 23, 2010 [Taoyuan, Taiwan]: With an increasing number of drug delivery devices, primarily auto injectors and pen injectors, under …
Pfizer expands Lipitor recall
December 24, 2010Manufacturing and Production Lipitor, Pfizer, manufacturing compliance, recalls
Pfizer has been forced to recall another 19,000 bottles of its cholesterol-lowering drug Lipitor in the US after consumers reported …
GSK’s patient access scheme for Votrient sways NICE
December 24, 2010Sales and Marketing GSK, GlaxoSmithKline, NICE, Votrient, pazopanib, rcc, renal cell carcinoma
NICE has recommended GlaxoSmithKline’s kidney cancer drug Votrient in final draft guidance after the pharma company offered to implement a …
Digital Pharma: Industry still cautious about social media
December 23, 2010Medical Communications Deloitte, Digital Pharma blog, doctors' social networks, social media, social networking
Life sciences companies remain cautious about using social networks, such as the healthcare professional community Sermo, largely because of a …
Novartis submits meningococcal vaccine Bexsero for European approval
December 23, 2010Sales and Marketing Bexsero, MenB, Novartis, Vaccine, bacterial meningitis, bloodstream infection sepsis, meningococcal disease, meningococcal vaccine
Novartis has submitted its meningococcal vaccine Bexsero to European regulators for marketing approval. If approved the drug will be the …
2010: Pharma’s year in review
December 23, 2010Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2010, Avandia, China, European healthcare spending, GSK, Obama, year in review
2010 saw a harsh new economic reality dominate decisions in the US and Europe, but pharma seized on opportunities in …
PCTs look to save millions with new cuts
December 23, 2010Sales and Marketing GP consortia, NHS, NHS cuts, NHS reforms, PCTs, generic prescribing
The NHS in England is cutting back on so-called ‘low priority’ procedures and looking to increase generic prescribing in order …
Gilead set to acquire Arresto for $225 million
December 23, 2010Research and Development AB0024, Arresto, Cancer, Gilead, advanced solid tumours, ambrisentan, fibrotic diseases, idiopathic pulmonary fibrosis
Gilead Sciences is set to acquire fellow California, US-based biotech Arresto for $225 million to bolster its early stage pipeline. …
Service Insight: New year, new resolution and priorities for 2011
December 23, 2010Medical Communications Jo Spadaccino, Pegasus PR, Service Insight, Talking Point
SERVICE INSIGHTNow the nights have drawn in and as Christmas music drives this writer to distraction, my attention has been …
Digital Pharma: FDA delays social media guidance until 2011
December 22, 2010Medical Communications Digital Pharma blog, FDA, social media
The FDA will release its hotly-anticipated social media guidance for pharma companies in a piecemeal fashion, beginning in the first …
AstraZeneca takes $445m hit to halt motavizumab
December 22, 2010Research and Development AZ, AstraZeneca, MedImmune, motavizumab, respiratory, respiratory syncytial virus
AstraZeneca has withdrawn a US licence application for its biologic respiratory treatment motavizumab in a move that will cost the …
Novartis blood cancer drug impresses in late stage trial
December 22, 2010Research and Development, Sales and Marketing INC424, Novartis, blood cancer, myelofibrosis, orphan drug
Novartis has released positive phase III results of its myelofibrosis drug INC424 showing it met its primary endpoint of reducing …
Novo to develop oral insulin
December 22, 2010Research and Development Emisphere, Novo Nordisk, diabetes, insulin, oral insulin, type I diabetes
Novo Nordisk is to develop an oral formulation of insulin with US biotech company Emisphere Technologies. The New Jersey-based biotech …
BMS licences phase II HIV compound festinavir
December 22, 2010Research and Development BMS, Bristol-Myers Squibb, HIV, NRTI, Oncolys BioPharma, festinavir, nucleoside reverse transcriptase inhibitor
Bristol-Myers Squibb is to pay hundreds of millions of dollars to a Japanese biotech firm to get its hands on …
Liberating the NHS … whether it likes it or not
December 22, 2010Sales and Marketing GP consortia, NHS, NHS board, NHS reforms, value-based pricing
When health secretary Andrew Lansley announced plans in July to abolish the management structure of England’s health service, and hand …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
